Home/Research Insights/Australian Peptide Research Landscape
Research Landscape
November 22, 202512 min read

Australian Peptide Research Landscape

Key institutions, funding opportunities, careers, and emerging trends in Australian peptide and protein science.

Australia's Growing Prominence in Peptide Research

Australia has established itself as a global leader in peptide and protein science, leveraging its unique biodiversity, world-class research infrastructure, and collaborative ecosystem to drive innovation. The Australian peptide synthesis market, valued at approximately AUD $180 million and growing at 8.4% CAGR, represents a significant opportunity for researchers and industry professionals.

The nation's peptide research landscape is characterised by distinctive strengths: discovery of novel peptides from unique flora and fauna, pioneering cyclotide research, advanced structural biology capabilities, and strong industry-academia partnerships that accelerate translation from bench to bedside.

ARC Centre of Excellence: CIPPS

Australia's Premier Peptide Research Network

The ARC Centre of Excellence for Innovations in Peptide and Protein Science (CIPPS) stands as the centrepiece of Australian peptide research. Headquartered at the University of Queensland, CIPPS brings together Australia's leading peptide scientists in a collaborative network spanning multiple institutions.

$35M
ARC Funding (7 years)
$54M
Partner Contributions
~$90M
Total Investment

Leadership

DC
Professor David Craik - Director, University of Queensland

Internationally recognised expertise in cyclotide research and peptide structural biology

RP
Professor Rich Payne - Deputy Director, University of Sydney

2025 ARC Laureate Fellowship ($3.9M) for protein modification research

Industry Partners

AstraZenecaNovo NordiskInnovate AgContract Research Organisations

Major University Research Centres

University of Queensland: Institute for Molecular Bioscience

Houses Australia's most comprehensive peptide research capabilities and serves as the physical home for much of CIPPS's research activities.

Key Achievement: Cyclotides

Discovery of the largest known family of circular proteins with cyclic backbone, cystine knot topology, exceptional stability, and oral bioavailability potential.

University of Sydney: School of Chemistry & Charles Perkins Centre

Professor Richard Payne's group focuses on technologies for accessing precisely modified peptides and proteins. Sydney Mass Spectrometry provides access to 20 mass spectrometers for proteomics and metabolomics.

Monash University: Institute of Pharmaceutical Sciences

Major centre for peptide drug discovery with strengths in medicinal chemistry and pharmacology. Research includes venom-derived peptides, agricultural bioinsecticides, and GLP-1 receptor research.

WEHI (Walter and Eliza Hall Institute)

Australia's oldest medical research institute (1915). Research across cancer, diabetes, obesity, immunology, and neuroscience using peptide and protein biochemistry.

Garvan Institute

Research on gastrointestinal peptides including Peptide YY (PYY), inflammation research, and discovery of molecules that switch appetite on and off.

Government Funding Bodies and Grant Opportunities

Australian Research Council (ARC)

Australian Laureate Fellowships (2025)

$65.3 million for 17 fellowships. Each provides Professional Level E salary, 2 Postdoctoral positions (5 years each), 2 Postgraduate positions (4 years each), up to $300,000/year project funding.

Discovery Program

Supports investigator-driven research across peptide chemistry, structural biology, and related disciplines.

NHMRC (2025 Funding Outcomes)

$653.8M+
Total Committed
345
Grants Funded

Key Date: Investigator Grants 2026 opens 4 June 2025, closes 30 July 2025.

Medical Research Future Fund (MRFF)

$20 billion long-term investment in priority-driven Australian health and medical research.

2024 BioMedTech Incubator
National Critical Research Infrastructure (up to $63M)
Stem Cell Therapies Mission (up to $31.5M)
Brain Cancer Discovery Grants

Emerging Research Trends in Australia

Native Peptide Discovery

  • Marine venom peptides from cone snails and sea anemones
  • Cyclotides from Australian plants
  • Antimicrobial peptides from native wildlife (platypus, marsupials)

AI & Computational Approaches

  • ML predicted ~1M new antimicrobial peptides from global microbiome
  • 79/100 tested peptides showed activity
  • AlphaFold2 for structure prediction

Metabolic Disease Research

  • GLP-1 receptor science for diabetes/obesity
  • DACRA (dual amylin and calcitonin receptor agonist) research
  • Cryo-EM studies of receptor mechanisms

Career Opportunities

  • PhD programs in peptide/protein science
  • Postdoc positions: $135,388-$155,696 + 17% super
  • Industry R&D in pharma/biotech

Frequently Asked Questions

What is CIPPS and why is it important?

CIPPS (ARC Centre of Excellence for Innovations in Peptide and Protein Science) is Australia's premier peptide research network with nearly $90 million in funding, discovering new peptides from Australian flora and fauna and developing innovative solutions for health, agriculture, and industry.

What qualifications do I need for a peptide research career?

Entry-level positions typically require a PhD in chemistry, biochemistry, pharmacology, or related fields. Postdoctoral experience is essential for academic careers. Strong backgrounds in organic chemistry, protein biochemistry, analytical techniques (HPLC, mass spectrometry), and computational methods are highly valued.

What makes Australian peptide research unique globally?

Australia's unique biodiversity provides a rich source of novel peptides, including cyclotides from native plants and venom peptides from cone snails and spiders. Australian researchers have pioneered cyclotide research and developed expertise in discovering bioactive compounds from native species unavailable elsewhere.

Connecting with the Research Community

Australian Society for Biochemistry and Molecular Biology (ASBMB)

Membership Benefits:
  • • Access to ComBio national conferences
  • • Networking opportunities
  • • Symposia and workshop support
  • • Educational publications
Upcoming Events:
ComBio 2026

29 September - 1 October 2026

ICC Sydney

Related Articles

Important Notice

This article provides educational information about peptide research for qualified laboratory professionals, researchers, students, and industry professionals in Australia. All peptides discussed are for RESEARCH USE ONLY and are not intended for human consumption, diagnostic use, or therapeutic applications outside of properly authorised clinical trials and approved therapeutic use.